In this in-person discussion, we will dive into metastatic breast cancer (ESR1 mutation) insights including initial and subsequent treatments, understanding biomarkers, and reviewing an example treatment strategy.

The next installment of SMPH Collaborate will be held on Friday, November 22 from 3-5 p.m. in Health Sciences Learning Center Room 1345.